Jacqueline Grant

Jacqueline Grant, also known as Jackie Grant, is a Principal at Abingworth, a transatlantic life sciences investment firm.13 She has over 15 years of experience in the life sciences industry, encompassing various aspects such as science, research, business development, and venture investing.12

Professional Background

Jackie joined Abingworth in November 2018 and works across the firm's offices in Boston, London, and Menlo Park.1 Her role involves:

• Sourcing and evaluating new investment opportunities
• Supporting existing venture investments
• Participating in company creation efforts
• Representing Abingworth on several company boards

Board Positions

Jackie represents Abingworth on the boards of:

• Atsena Therapeutics
• Glycomine
• Nido Biosciences

She also serves as an observer on the board of Anjarium Biosciences.12

Previous Experience

Before joining Abingworth, Jackie's career included:

• Senior Associate at SVHealth Investors
• Business Development Group at Genentech, focusing on partnering activities in neuroscience1

Education

Jackie holds impressive academic credentials:

• PhD in Neuroscience from Stanford School of Medicine
• MBA from Stanford Graduate School of Business12

Her educational background combines scientific expertise with business acumen, which is valuable in her role as a life sciences investor.

Investment Focus

At Abingworth, Jackie is involved in various investment activities, including:

• Active participation in company creation efforts
• Responsibility for emerging new companies in stealth mode
• Evaluating opportunities across multiple therapeutic areas and deal structures1

Jackie Grant's diverse experience and educational background make her a valuable asset to Abingworth's investment team, contributing to the firm's strategy of supporting innovative life science companies.